Elsevier

Thrombosis Research

Volume 59, Issue 1, 1 July 1990, Pages 51-59
Thrombosis Research

Paper
Hypofibrinolysis associated with vasculopathy in non insulin dependent diabetes mellitus

https://doi.org/10.1016/0049-3848(90)90270-MGet rights and content

Abstract

The pathogenesis of diabetic vasculopathy has been related to modifications in hemostasis and fibrinolysis. 50 non insulin dependent diabetes mellitus patients have been studied. Euglobulin clot lysis time, fibrin plate, tissue plasminogen activator (t-PA) antigen, plasminogen activator inhibitor (PAI) activity, Protein C and S, cholesterol, triglycerides and Hb Alc were determined in blood samples. Diabetic patients showed decreased fibrinolytic activity, as measured by ECLT, with clearly increased PAI levels. Fibrinolytic response to venous occlusion was lower than normal. Vascular complications were associated both with an even higher PAI activity and with a decreased fibrinolytic response to venous occlusion. Elevated PAI activity and decreased fibrinolytic response to stimulus may contribute to vascular disease in diabetes.

References (26)

  • G.R. Fearnley et al.

    Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity

    Brit Med J

    (1963)
  • J. Auwerx et al.

    Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus

    Arteriosclerosis

    (1988)
  • M. Brownlee et al.

    Nonenzymatic glycosilation and the pathogenesis of diabetic complications

    Ann Int Med

    (1984)
  • Cited by (70)

    • Detection of early allograft dysfunction at 30 min of reperfusion in liver transplantation: An intraoperative diagnostic tool with real time assessment of graft function

      2020, American Journal of Surgery
      Citation Excerpt :

      A fibrinolytic response can be generated in healthy individuals by applying a tourniquet to the arm promoting the release of tPA and this results in increased local fibrinolytic activity in the ischemic arm.32 Hypofibrinolysis, defined by this measurement has been associated with thrombotic complications in multiple clinical settings.32–34 Liver transplant serves as another model for identifying hypofibrinolysis, as removal of the liver results in lack of clearance of tPA, and therefore it would be expected that all liver transplant patients would experience hyperfibrinolysis during the anhepatic phase of surgery.

    • The potent different risk factors for cerebral infarction in young patients with and without type 2 diabetes: Subanalysis of the Young Cerebral Infarction Study (YCIS)

      2012, Atherosclerosis
      Citation Excerpt :

      However, it is possible to speculate that the diabetes induced increasing level of serum fibrinogen render the cerebral vessels prone to block. In diabetic patients, platelet aggregability, coagulability, and plasminogen activator inhibitor levels are increased, whereas fibrinolytic activity is decreased [21,22]. Initial stroke severity did not differ between diabetic and non-diabetic patients, in agreement with a hospital-based series that found diabetic individuals had more severe strokes [18] and a poorer neurologic outcome [23]; however, the number of known diabetics studied was very small.

    View all citing articles on Scopus
    View full text